 | | PRD_002254 | | Name: | (2~{S})-~{N}-[(2~{S})-3-methoxy-1-(naphthalen-1-ylmethylamino)-1-oxidanylidene-propan-2-yl]-4-oxidanylidene-2-(3-phenylpropanoylamino)-4-piperidin-1-yl-butanamide | | Formula: | C33 H40 N4 O5 | | Definition date: | 2017-01-11 | | Last modified: | 2023-11-03 |
|
 | | PRD_002255 | | Name: | N,N-diethyl-N~2~-(3-phenylpropanoyl)-L-asparaginyl-N-[(naphthalen-1-yl)methyl]-L-alaninamide | | Formula: | C31 H38 N4 O4 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002256 | | Name: | N-tert-butoxy-N~2~-(5-methyl-1,2-oxazole-3-carbonyl)-L-asparaginyl-O-methyl-N-[(naphthalen-1-yl)methyl]-L-serinamide | | Formula: | C28 H35 N5 O7 | | Definition date: | 2017-01-11 | | Last modified: | 2023-11-03 |
|
 | | PRD_002257 | | Name: | Globomycin | | Formula: | C32 H57 N5 O9 | | Definition date: | 2019-08-28 | | Last modified: | 2023-11-03 |
|
 | | PRD_002282 | | Name: | (3S,6S,9S,15aR)-6,9-dibenzyl-3-{6,6-dihydroxy-6-[(2S)-oxiran-2-yl]hexyl}octahydro-2H-pyrido[1,2-a][1,4,7,10]tetraazacyclododecine-1,4,7,10(3H,12H)-tetrone | | Formula: | C34 H44 N4 O7 | | Definition date: | 2017-09-13 | | Last modified: | 2023-11-03 |
|
 | | PRD_002285 | | Name: | N~2~-[(2S)-2-{[3-(6-chloro-1,3-benzothiazol-2-yl)-N-propanoyl-L-alanyl]amino}-2-cyclopentylacetyl]-N-[(4R)-3,4-dihydro-2H-1-benzopyran-4-yl]-N~6~,N~6~-dimethyl-L-lysinamide | | Formula: | C37 H49 Cl N6 O5 S | | Definition date: | 2018-02-28 | | Last modified: | 2023-11-03 |
|
 | | PRD_002289 | | Name: | 3-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]propanamide | | Formula: | C68 H85 N13 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002290 | | Name: | 4-[(3R,6S,9S,12S,15S,18S,21S,24R,27S)-21-(2-amino-2-oxoethyl)-9-(3-aminopropyl)-3,24,27-tribenzyl-15-[(4-hydroxyphenyl)methyl]-6-(2-methylpropyl)-2,5,8,11,14,17,20,23,26,29-decaoxo-12-(propan-2-yl)-2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29-octacosahydro-1H-1,4,7,10,13,16,19,22,25,28-benzodecaazacyclohentriacontin-18-yl]butan-1-aminium | | Formula: | C69 H90 N13 O12 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002314 | | Name: | INNN(ABU) Cyclic peptide inhibitor | | Formula: | C22 H36 N8 O8 | | Definition date: | 2019-04-17 | | Last modified: | 2023-11-03 |
|
 | | PRD_002338 | | Name: | N-(3-phenylpropanoyl)-3-(1,3-thiazol-4-yl)-L-alanyl-N-[(1S,2S)-1-(1,3-benzothiazol-2-yl)-5-carbamimidamido-1-hydroxypentan-2-yl]-L-valinamide | | Formula: | C33 H42 N8 O4 S2 | | Definition date: | 2019-10-02 | | Last modified: | 2023-11-03 |
|
 | | PRD_002350 | | Name: | INHIBITOR ARC-1415 | | Formula: | C55 H106 N30 O8 | | Definition date: | 2021-08-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_002363 | | Formula: | C73 H120 N20 O13 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002365 | | Name: | phazolicin | | Formula: | C74 H104 N29 O27 S3 | | Definition date: | 2020-08-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002369 | | Name: | ecumicin | | Formula: | C83 H135 N14 O17 | | Definition date: | 2020-05-13 | | Last modified: | 2023-11-03 |
|
 | | PRD_002390 | | Name: | Papain-like protease peptide inhibitor VIR251 | | Formula: | C22 H33 N5 O7 | | Definition date: | 2020-05-20 | | Last modified: | 2023-11-03 |
|
 | | PRD_002391 | | Name: | covalently bound calpain inhibitor II | | Formula: | C19 H37 N3 O4 S | | Definition date: | 2020-06-17 | | Last modified: | 2023-11-03 |
|
 | | PRD_002392 | | Name: | UAW246 | | Formula: | C25 H36 N4 O6 | | Definition date: | 2020-06-17 | | Last modified: | 2023-11-03 |
|
 | | PRD_002394 | | Name: | UAW248 | | Formula: | C30 H45 N5 O7 | | Definition date: | 2020-06-17 | | Last modified: | 2023-11-03 |
|
 | | PRD_002435 | | Formula: | C49 H86 N5 O8 | | Definition date: | 2020-09-16 | | Last modified: | 2023-11-03 |
|
 | | PRD_002456 | | Name: | ecumicin | | Formula: | C83 H135 N14 O17 | | Definition date: | 2020-12-30 | | Last modified: | 2023-11-03 |
|
 | | PRD_002482 | | Name: | cyclic peptide MP-9903 | | Formula: | C71 H108 N17 O20 S2 | | Definition date: | 2021-09-22 | | Last modified: | 2023-11-03 |
|
 | | PRD_002489 | | Name: | lipid II mimetic, LPATA: Thr-in conformation | | Formula: | C53 H85 N14 O16 | | Definition date: | 2022-09-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_002510 | | Name: | Minihepcidin PR73 | | Formula: | C86 H136 N21 O15 S | | Definition date: | 2022-12-07 | | Last modified: | 2023-11-03 |
|
 | | PRD_002417 | | Name: | Ac-VRHA-conh-[4-(4-butyl)-phenoxy-1-phenyl-2-butyl] | | Formula: | C43 H66 N10 O7 | | Definition date: | 2023-10-25 | | Last modified: | 2023-10-25 |
|
 | | PRD_002387 | | Name: | tert-butyl N-[5-phenyl-3-(2-phenylethylcarbamoyl)thiophen-2-yl]carbamate | | Formula: | C24 H26 N2 O3 S | | Definition date: | 2023-09-27 | | Last modified: | 2023-09-27 |
|
